Lysophosphatidic acid production from lysophosphatidylcholine by lysophospholipase D activity of autotaxin in plasma of women with normal and adverse pregnancies

Prostaglandins Other Lipid Mediat. 2022 Dec:163:106670. doi: 10.1016/j.prostaglandins.2022.106670. Epub 2022 Aug 11.

Abstract

To identify biomarker lipids causing preterm delivery, we focused on lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA). The results of liquid chromatography-tandem mass spectrometry revealed that plasma levels of LPCs and LPAs were higher in the first and third (T3) trimesters of human normal and adverse pregnancies than in the second trimester, suggesting the direct metabolic conversion of LPC to LPA by lysophospholipase D (lysoPLD) activity of autotaxin. The elevated LPC and LPA levels in women with preterm deliveries in T3 were higher than in women with term deliveries under normal pregnancy in T3. We measured lysoPLD activity of diluted sera of pregnant women by quantification of choline released from exogenous LPC, and found progressive increases of lysoPLD activities in women with normal and adverse pregnancies. Ratios of lysoPLD activities for linoleoyl LPC to that for palmitoyl LPC were found to be decreased in pregnant women compared to that in non-pregnant women. These results may be due to the altered patterns of endogenous modulators for autotaxin and the profiles of the bound metal ion.

Keywords: Adverse pregnancy outcome; Autotaxin; Cord blood; Liquid chromatography-tandem mass spectrometry; Maternal blood; Trimester of pregnancy.

MeSH terms

  • Female
  • Humans
  • Infant, Newborn
  • Lysophosphatidylcholines*
  • Lysophospholipids / metabolism
  • Phosphoric Diester Hydrolases* / metabolism
  • Pregnancy

Substances

  • alkylglycerophosphoethanolamine phosphodiesterase
  • lysophosphatidic acid
  • Lysophosphatidylcholines
  • Phosphoric Diester Hydrolases
  • Lysophospholipids